协和医学杂志

2021, v.12(01) 13-17

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

新型冠状病毒肺炎合并肥胖症的评估与治疗策略
Evaluation and Treatment of Coronavirus Disease 2019 with Obesity

王诗蕊;陈适;朱惠娟;
WANG Shi-rui;CHEN Shi;ZHU Hui-juan;Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;

摘要(Abstract):

新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)已成为危及全球的传染性疾病,重症患者死亡风险极高。临床研究显示,肥胖症是COVID-19患者发生重症及死亡的独立危险因素。对于合并肥胖症的COVID-19患者,应尽早评估肥胖相关合并症,并在营养、气道管理、抗凝、合并症控制等方面采取更积极的干预措施,以改善预后。
The pandemic of coronavirus disease 2019(COVID-19) has spread worldwide and the mortality is high in severe COVID-19 patients. Clinical studies suggested that obesity is an independent risk factor for severe and dead cases of COVID-19. For COVID-19 patients with obesity, early evaluation of obesity-related comorbidities and aggressive treatments, including diet control, airway management, anticoagulant thromboprophylaxis, and management of comorbidities, are encouraged to improve their prognosis.

关键词(KeyWords): 新型冠状病毒肺炎;肥胖症;评估;治疗
coronavirus disease 2019;obesity;evaluation;treatment

Abstract:

Keywords:

基金项目(Foundation): 中国医学科学院医学与健康科技创新工程(2016-I2M-1-002)~~

作者(Author): 王诗蕊;陈适;朱惠娟;
WANG Shi-rui;CHEN Shi;ZHU Hui-juan;Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Endocrinology, Key Laboratory of Endocrinology, National Health Commission of the People's Republic of China, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College;

Email:

DOI:

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享